A Study of the Safety and Effectiveness of the Experimental Medicine Tisotumab Vedotin for Solid Tumors
a study on Colorectal Cancer Lung Cancer Pancreatic Cancer Head and Neck Squamous Cell Carcinoma Solid Tumor
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Davis
- Dates
- study startedestimated completion
- Principal Investigator
- May Cho(ucdavis)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Health
- May Cho (ucdavis)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Seattle Genetics, Inc.
- ID
- NCT03485209
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated